好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Assessing Neurological Service Availability and Institutional Preparedness in Africa
Global Health and Neuroepidemiology
P5 - Poster Session 5 (11:45 AM-12:45 PM)
20-003
To assess institutional readiness and resource availability for neurological care delivery across diverse healthcare settings in Africa.

Workforce shortages, limited diagnostic infrastructure, and inconsistent access to essential medications contribute to significant gaps in neurology care across African countries.

A continent-wide, cross-sectional survey was conducted among neurologists, neurosurgeons, and other healthcare professionals familiar with the capacity of neurology care at their practice institutions. Distributed between January 2024 and May 2025, the 116-item survey covered ten domains, including workforce composition, inpatient and outpatient clinical volume, diagnostic and therapeutic tools, education and training, telehealth capacity, and research engagement.

Ninety respondents from 19 African countries participated, with the largest representation from Nigeria, Tanzania, and Zambia. Most worked in public institutions (87.8%), though only one-third had dedicated neurology departments. Neurologists and neurosurgeons were available at most sites but often in limited numbers. Nearly two-thirds (62.5%) had dedicated inpatient neurology wards, while outpatient clinics were more common (84.1%), with stroke, epilepsy, and migraine most frequently reported. Majority of survey participants noted wait times to see a neurologist of less than one month for initial visits and 1–3 months for follow-up. A majority of institutions were affiliated with medical schools (80.7%), with neurology and neurosurgery residency programs present in over 70% of sites, though training capacity varied. Telehealth availability was low (23.5%), with major barriers including lack of software and limited partnerships. Access to basic diagnostics (i.e. CT, EEG, lumbar puncture) and essential therapies (i.e. antihypertensives, antiplatelets, anticonvulsants) was widespread, while advanced diagnostics (i.e. PET, evoked potentials, transcranial Doppler) and therapies (i.e. thrombolysis, thrombectomy, plasma exchange) were largely unavailable.

Substantial disparities exist in the neurological workforce infrastructure, diagnostics, therapeutics, and training across the African continent. Strengthened investment in infrastructure, workforce development, and modern technologies is critical to address the rising burden of neurological conditions across the region.
Authors/Disclosures
Soonmyung Hwang (Icahn School of Medicine at Mount Sinai)
PRESENTER
Mr. Hwang has nothing to disclose.
Sarah S. Matuja Ms. Matuja has nothing to disclose.
Meron Gebrewold, MD (Addis Ababa University) Dr. Gebrewold has nothing to disclose.
Sarah Wahlster, MD Dr. Wahlster has nothing to disclose.
Deanna Saylor, MD, MHS (Johns Hopkins Hospital) Dr. Saylor has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from 好色先生. Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and 好色先生al Innovation Commitees with American Neurological Association that is relevant to AAN interests or activities.
Morgan Prust, MD (Yale University School of Medicine) Dr. Prust has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Edelman & Edelman, PC.